BioScience Health Innovations BHIC Income Statement (2019-2026)

OTC BHIC
$4.01 -0.99 (-19.80%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
0.03M0.07M0.19M0.30M0.28M0.38M0.57M0.61M1.23M1.76M1.13M1.57M0.75M1.04M
Cost of Revenue (Quarter)
0.00M0.01M0.03M0.07M0.04M0.07M0.15M0.27M0.33M0.68M0.43M1.00M0.27M0.38M
Gross Profit (Quarter)
0.03M0.06M0.16M0.24M0.23M0.31M0.42M0.34M0.90M1.07M0.70M0.57M0.49M0.66M
Operating items
Selling, General & Administrative (Quarter)
0.00M0.01M0.03M0.05M0.03M0.09M0.14M0.21M0.26M0.28M0.22M0.35M0.30M0.43M0.54M0.58M0.66M0.63M0.80M
Other Operating Expenses (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.03M0.04M0.08M0.13M0.07M0.09M0.07M
Operating Expenses (Quarter)
0.00M0.01M0.03M0.05M0.03M0.10M0.15M0.22M0.27M0.29M0.24M0.37M0.33M0.47M0.62M0.71M0.73M0.72M0.88M
Operating Income (Quarter)
-0.00M-0.01M-0.03M-0.05M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.06M0.01M0.43M0.46M-0.01M-0.16M-0.23M-0.22M
EBIT (Quarter)
-0.00M-0.01M-0.03M-0.05M0.02M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.06M0.01M0.43M0.46M-0.01M-0.16M-0.23M-0.22M
Non-operating items
Other Non Operating Income (Quarter)
0.01M
Net income details
EBT (Quarter)
-0.00M-0.01M-0.02M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.05M0.01M0.42M0.45M-0.01M-0.16M-0.23M-0.22M
Tax Provisions (Quarter)
0.02M-0.03M
Profit After Tax (Quarter)
-0.00M-0.01M-0.02M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.06M0.01M0.43M0.46M-0.01M-0.23M-0.23M-0.19M
Income from Continuing Operations (Quarter)
-0.00M-0.01M-0.02M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.05M-0.01M0.42M0.45M-0.01M-0.16M-0.23M-0.19M
Consolidated Net Income (Quarter)
-0.00M-0.01M-0.02M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.05M-0.01M0.42M0.45M-0.01M-0.16M-0.23M-0.19M
Income towards Parent Company (Quarter)
-0.00M-0.01M-0.02M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.05M-0.01M0.42M0.45M-0.01M-0.16M-0.23M-0.19M
Net Income towards Common Stockholders (Quarter)
-0.00M-0.01M-0.02M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.05M-0.01M0.42M0.45M-0.01M-0.16M-0.23M-0.19M
Additional items
EPS (Basic) (Quarter)
0.000.000.00-0.010.00-0.01-0.010.000.000.000.000.000.000.000.010.010.00-0.01-0.02-0.02
EPS (Diluted) (Quarter)
0.000.000.000.000.000.000.010.010.00-0.01-0.02-0.02
Shares Outstanding (Quarter)
5.46M5.46M5.46M5.46M5.46M5.46M13.86M39.84M40.36M33.76M41.39M41.60M42.09M41.93M43.92M43.92M10.98M10.98M11.38M11.68M
Shares Outstanding (Diluted) (Quarter)
40.36M33.76M41.39M42.02M42.09M42.35M44.34M44.34M10.98M11.40M11.38M11.68M
Shares Outstanding (Entity) (Quarter)
5.46M5.46M5.46M5.46M5.46M5.46M13.86M40.31M40.79M33.76M41.60M41.60M42.10M43.92M43.92M43.92M10.98M10.98M11.42M11.75M
EBITDA (Quarter)
-0.00M-0.01M-0.03M-0.05M0.02M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.06M0.01M0.43M0.46M-0.01M-0.16M-0.23M-0.22M
Interest Expenses (Quarter)
450.000.02M0.01M0.00M0.00M0.00M
Tax Rate (Quarter)
242.82%14.75%